BE894358A - Composes de benzothiazoline - Google Patents

Composes de benzothiazoline

Info

Publication number
BE894358A
BE894358A BE2/59831A BE2059831A BE894358A BE 894358 A BE894358 A BE 894358A BE 2/59831 A BE2/59831 A BE 2/59831A BE 2059831 A BE2059831 A BE 2059831A BE 894358 A BE894358 A BE 894358A
Authority
BE
Belgium
Prior art keywords
benzothiazoline
compounds
benzothiazoline compounds
Prior art date
Application number
BE2/59831A
Other languages
English (en)
French (fr)
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of BE894358A publication Critical patent/BE894358A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE2/59831A 1981-09-12 1982-09-10 Composes de benzothiazoline BE894358A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56144148A JPS5846079A (ja) 1981-09-12 1981-09-12 ベンゾチアゾリン環を有するエ−テル類

Publications (1)

Publication Number Publication Date
BE894358A true BE894358A (fr) 1983-01-03

Family

ID=15355326

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2/59831A BE894358A (fr) 1981-09-12 1982-09-10 Composes de benzothiazoline

Country Status (18)

Country Link
US (3) US4479949A (OSRAM)
JP (1) JPS5846079A (OSRAM)
AT (1) AT379592B (OSRAM)
AU (1) AU541223B2 (OSRAM)
BE (1) BE894358A (OSRAM)
CA (1) CA1169860A (OSRAM)
CH (1) CH654001A5 (OSRAM)
DE (1) DE3248957T1 (OSRAM)
DK (1) DK164403C (OSRAM)
ES (2) ES515655A0 (OSRAM)
FI (1) FI68232C (OSRAM)
FR (1) FR2512820B1 (OSRAM)
GB (1) GB2115815B (OSRAM)
IT (1) IT1196423B (OSRAM)
NL (1) NL8220310A (OSRAM)
NO (1) NO831653L (OSRAM)
SE (1) SE444681B (OSRAM)
WO (1) WO1983000865A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56164877A (en) * 1980-05-23 1981-12-18 Fujitsu Ltd Manufacture of head for thermal printer
JPS5846079A (ja) * 1981-09-12 1983-03-17 Santen Pharmaceut Co Ltd ベンゾチアゾリン環を有するエ−テル類
DK143684A (da) * 1983-03-12 1984-09-13 Bayer Ag Anvendelse af pyrazolonderivater som lipoxygenasehaemmer ved terapi af isaer ischaemi og hjerterytmeforstyrrelser
JPS60139679A (ja) * 1983-12-27 1985-07-24 Santen Pharmaceut Co Ltd ２−アリ−ルベンゾチアゾリン誘導体
JPS60207396A (ja) * 1984-03-31 1985-10-18 ロ−ム株式会社 配線基板
JPS61110568A (ja) * 1984-10-31 1986-05-28 アルカテル・エヌ・ブイ プリンタ装置
US4728651A (en) * 1985-10-24 1988-03-01 Hoechst-Roussel Pharmaceuticals Inc. Antihypertensive thieno-isoxazoles and -pyrazoles
JPS62221679A (ja) * 1986-03-19 1987-09-29 Santen Pharmaceut Co Ltd ベンゾチアゾリン誘導体
US5147881A (en) * 1990-11-14 1992-09-15 Pfizer Inc 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
NZ535987A (en) * 2002-03-29 2006-08-31 Santen Pharmaceutical Co Ltd k-opioid receptor agonist comprising 2-henylbenzothiazoline derivative
CA2907921C (en) * 2013-03-22 2021-09-07 Ayumi Pharmaceutical Corporation Inhibition of il-2 production

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2996512A (en) * 1961-08-15 Therapeutic derivatives of aryl-
US3117124A (en) * 1957-03-20 1964-01-07 Olin Mathieson Benzothiazole, benzothiazine, and benzothiazepine compounds
FR1255312A (fr) * 1957-10-31 1961-03-10 Crookes Lab Ltd Dérivés des aryl-benzothiazoles et leur mode de préparation
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
BE754245A (fr) * 1969-08-01 1970-12-31 Sumitomo Chemical Co Derives d'acides phenoxy carboxyliques
US3574218A (en) * 1969-08-11 1971-04-06 Egyt Gyogyszervegyeszeti Gyar 2-aryl- or aralkyl-substituted benzazole derivatives
US3720683A (en) * 1970-09-02 1973-03-13 Squibb & Sons Inc 2-phenyl-3-acylbenzothiazolines and their oxides
JPS5371071A (en) * 1976-12-08 1978-06-24 Teijin Ltd Alpha-phenoxyacetic acid derivs.
JPS57179175A (en) * 1981-04-30 1982-11-04 Shinzo Kano Preparation of 2-benzothiazolinone derivative or salt thereof
JPS5846079A (ja) * 1981-09-12 1983-03-17 Santen Pharmaceut Co Ltd ベンゾチアゾリン環を有するエ−テル類

Also Published As

Publication number Publication date
AU8902682A (en) 1983-03-28
ATA904882A (de) 1985-06-15
DK211283A (da) 1983-05-11
DE3248957C2 (OSRAM) 1989-09-21
AU541223B2 (en) 1984-12-20
DE3248957T1 (de) 1983-10-20
ES8308552A1 (es) 1983-09-16
US4552969A (en) 1985-11-12
DK164403C (da) 1992-11-16
FR2512820B1 (fr) 1986-11-21
GB2115815B (en) 1985-06-19
FI831431A0 (fi) 1983-04-27
ES8407033A1 (es) 1984-08-16
CA1169860A (en) 1984-06-26
IT1196423B (it) 1988-11-16
GB2115815A (en) 1983-09-14
SE8302352L (sv) 1983-04-26
US4558125A (en) 1985-12-10
GB8311096D0 (en) 1983-05-25
FI68232C (fi) 1985-08-12
SE444681B (sv) 1986-04-28
FI68232B (fi) 1985-04-30
IT8223146A0 (it) 1982-09-07
DK211283D0 (da) 1983-05-11
ES515655A0 (es) 1983-09-16
SE8302352D0 (sv) 1983-04-26
ES522386A0 (es) 1984-08-16
DK164403B (da) 1992-06-22
FR2512820A1 (fr) 1983-03-18
US4479949A (en) 1984-10-30
JPS5846079A (ja) 1983-03-17
AT379592B (de) 1986-01-27
NO831653L (no) 1983-05-10
FI831431L (fi) 1983-04-27
WO1983000865A1 (fr) 1983-03-17
NL8220310A (nl) 1983-08-01
CH654001A5 (de) 1986-01-31

Similar Documents

Publication Publication Date Title
DK555782A (da) Oxabicycloalkaner
DK573482A (da) Tetrahydrophthalimidforbindelser
AT385411B (de) Beruhigungssauger
AT382116B (de) Geraeuschgedaempftes schienenrad
AT372860B (de) Schipaar
AT376385B (de) Drehmaschine
PT74591B (pt) Improved wing-sail
FI821142A0 (fi) Hoeftledprotes
DK211283D0 (da) Benzothiazolinforbindelser
DK155096C (da) Dirkefri cylinderlaas
FI823741L (fi) Digitalt behandlingssystem foer televisiossignal
FR2516086B1 (fr) Composes triarylboraneisocyano-metal
DK14983A (da) Sadeludtags-fitting
DE3262401D1 (de) Thiazolidine derivatives
AT384100B (de) Drehrohrofen
FR2510990B1 (fr) Alcoylamides de carboxyalcanoylpeptides
FR2510568B1 (fr) Composes antiarythmiques phenethylpiperidiniques
BR8109031A (pt) Derivados de tiazolinotriazina
AT385733B (de) Skibob
DE3269141D1 (de) Benzylazole derivatives
FI823977L (fi) Anordning foer vaermevaexling
AT368631B (de) Zweibein
FI822475L (fi) Gaengsaekringselement
RO83661A2 (ro) Tija de honuire
AR229844A1 (es) Mejoras en asiento-escalera

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANTEN PHARMACEUTICAL CO. LTD

Effective date: 19970930